Ossiam Purchases 97,910 Shares of MetLife, Inc. (NYSE:MET)

Ossiam boosted its position in MetLife, Inc. (NYSE:MET) by 325.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 127,995 shares of the financial services provider’s stock after purchasing an additional 97,910 shares during the period. Ossiam’s holdings in MetLife were worth $10,480,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Retirement Wealth Solutions LLC purchased a new stake in MetLife during the 4th quarter valued at about $32,000. Sierra Ocean LLC purchased a new stake in shares of MetLife during the fourth quarter valued at approximately $32,000. Graney & King LLC purchased a new position in shares of MetLife in the fourth quarter worth $34,000. Values First Advisors Inc. bought a new stake in MetLife during the 4th quarter valued at $36,000. Finally, Golden State Wealth Management LLC bought a new stake in MetLife in the 4th quarter worth $44,000. 94.99% of the stock is currently owned by institutional investors.

MetLife Stock Up 1.1 %

MET stock opened at $72.49 on Friday. The business has a 50 day moving average of $79.19 and a 200 day moving average of $82.12. The firm has a market cap of $49.38 billion, a PE ratio of 12.14, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, research analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

MET has been the topic of a number of recent analyst reports. Piper Sandler lifted their price objective on MetLife from $92.00 to $94.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 2nd. Wells Fargo & Company reduced their price objective on shares of MetLife from $97.00 to $91.00 and set an “overweight” rating on the stock in a research report on Thursday, April 10th. UBS Group raised their target price on shares of MetLife from $94.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, April 2nd. Morgan Stanley reduced their price target on shares of MetLife from $109.00 to $94.00 and set an “overweight” rating on the stock in a research report on Thursday, April 10th. Finally, Cowen reissued a “buy” rating on shares of MetLife in a research report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $92.46.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.